Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Evaluation of Estrogenic Effects of Phthalate Analogues Using in vitro and in vivo Screening Assays

  • Kim, Youn-Jung (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology) ;
  • Ryu, Jae-Chun (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology)
  • Published : 2006.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Phthalate analogues are a plasticizer and solvent used in industry. Phthalates were classified in the category of "suspected" endocrine disruptors. The purpose of our study was to screen and elucidate the endocrine disrupting activity of seven phthalate analogues. E-screen assay was performed in MCF-7 human breast cancer cells with seven phthalate analogues. In this cell proliferation assay, benzyl butyl phthalate (BBP) and dibutyl phthalate (DBP) showed high estrogenic activity. Their relative proliferation efficiencies (RPE) were 109 and 106%, respectively. In vitro estrogen receptor (ER) binding assay, BBP, di-n-octyl phthalate (DOP) and dinonyl phthalate (DNP) showed weak relative binding affinity (RBA: 0.02%) compared to $17{\beta}-estradiol\;(E2)$ (RBA: 100%). In uterotrophic assay, E2 produced a significant increase, whereas four tested phthalate analogues had potential estrogenic effects in vitro did not increased in uterus weight in immature rats. From these results, we demonstrated that phthalate analogues exhibit weak estrogenic activity in vitro assays at high concentrations. Although phthalates induced an increase in MCF-7 cell proliferation by an estrogenic effect, they could not induce a uterus weight increase in vivo. From these, we may suggest that these phthalate analogues are easily metabolized to inactive forms in vivo. Further investigation in other in vitro and in vivo experimental systems might be required.

Keywords

References

  1. Bauer, M.J. & Herrmann, R. Estimation of the environmental contamination by phthalic acid esters leaching from household wastes. Sci. Total Environ. 208, 49-57 (1997) https://doi.org/10.1016/S0048-9697(97)00272-6
  2. Choi, K.C. & Jeung, E.B. The biomarker and endocrine disruptors in mammals. J. Reprod. Dev. 49, 337-345 (2003) https://doi.org/10.1262/jrd.49.337
  3. Harris, C.A., Henttu, P., Parker, M.G. & Sumpter, J.P. The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect 105, 802-811 (1997) https://doi.org/10.2307/3433697
  4. Colborn, T., vom Saal, F.S. & Soto, A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect 101, 378-384 (1993) https://doi.org/10.2307/3431890
  5. Davis, D.L. et al. Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect 101, 372-377 (1993) https://doi.org/10.2307/3431889
  6. Eubanks, M.W. Hormones and health. Environ. Health Perspect 105, 482-486 (1997) https://doi.org/10.2307/3433574
  7. CERHR. NTP-CERHR Expert Panel Report on Di (2- ethylhexyl) Phthalate, http://cerhr.niehs.nih.gov/news/phthalates/DEHP-final.pdf.U.S. Department of Health and Human Services, National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction, Research Triangle Park, NC (2000)
  8. Huber, W.W., Grasl-Kraupp, B. & Schulte-Hermann, R. Hepatocarcinogenic potential of di (2-ethyl hexyl) phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26, 365-481 (1996) https://doi.org/10.3109/10408449609048302
  9. Moore, N.P. The oestrogenic potential of the phthalate esters. Reprod. Toxicol. 14, 183-192 (2000) https://doi.org/10.1016/S0890-6238(00)00068-X
  10. Harrison, P.T., Holmes, P. & Humfrey, C.D. Reproductive health in humans and wildlife: are adverse trends associated with environmental chemical exposure Sci. Total Environ. 205, 97-106 (1997) https://doi.org/10.1016/S0048-9697(97)00212-X
  11. Jobling, S. et al. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect 103, 582-587 (1995) https://doi.org/10.2307/3432434
  12. Sonnenschein, C. & Soto, A.M. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid Biochem. Mol. Biol. 65, 143- 149 (1998) https://doi.org/10.1016/S0960-0760(98)00027-2
  13. Ward, J.M. et al. Dissimilar patterns of promotion by di (2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 4, 1021-1029 (1983) https://doi.org/10.1093/carcin/4.8.1021
  14. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. March (2003)
  15. Asai, D. et al. Structural essentials of xenoestrogen dialkyl phthalates to bind to the estrogen receptors. Toxicol. Lett. 118, 1-8 (2000) https://doi.org/10.1016/S0378-4274(00)00253-8
  16. Routledge, E.J. & Sumpter, J.P. Structural features of alkylphenolic chemicals associated with estrogenic activity. J. Biol. Chem. 272, 3280-3288 (1997) https://doi.org/10.1074/jbc.272.6.3280
  17. Soto, A.M. et al. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect 103 (Suppl. 7), 113-122 (1995) https://doi.org/10.1289/ehp.95103s7113
  18. Picard, K., Lhuguenot, J.C., Lavier-Canivenc, M.C. & Chagnon, M.C. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule (s). Toxicol. Appl. Pharmacol. 172, 108-118 (2001) https://doi.org/10.1006/taap.2001.9141
  19. Baker, V.A. et al. Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. Food Chem. Toxicol. 37, 13-22 (1999) https://doi.org/10.1016/S0278-6915(98)00101-X
  20. Zacharewski, T.R. et al. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol. Sci. 46, 282-293 (1998)
  21. Nishihara, T. et al. Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J. Health Sci. 46, 282-298 (2000) https://doi.org/10.1248/jhs.46.282
  22. Coldham, N.G. et al. Evaluation of a recombinant yeast cell estrogen screening assay. Environ. Health Perspect 105, 734-742 (1997) https://doi.org/10.2307/3433729
  23. Sohoni, P. & Sumpter, J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158, 327-339 (1998) https://doi.org/10.1677/joe.0.1580327
  24. Paganetto, G. et al. Endocrine-disrupting agents on healthy human tissues. Pharmacol. Toxicol. 86, 24-29 (2000)
  25. Blair, R.M. et al. The estrogen receptor relative binding affinities of 188 batural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54, 138-153 (2000) https://doi.org/10.1093/toxsci/54.1.138
  26. Ema, M., Miyawaki, E. & Kawashima, K. Reproductive effects of butyl benzyl phthalate in pregnant and pseudopregnant rats. Reprod. Toxicol. 12, 127-132 (1998) https://doi.org/10.1016/S0890-6238(97)00127-5
  27. Ema, M., Miyawaki, E. & Kawashima, K. Effects of dibutyl phthalate on reproductive function in pregnant and pseudopregnant rats. Reprod. Toxicol. 14, 13-19 (2000) https://doi.org/10.1016/S0890-6238(99)00066-0
  28. Ashby, J. et al. Failure to confirm estrogenic activity for benzoic acid and clofibrate: implications for lists of endocrine-disrupting agents. Regul. Toxicol. Pharmacol. 26, 96-101 (1997) https://doi.org/10.1006/rtph.1997.1158
  29. Soto, A.M. & Sonnenschein, C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J. Steroid Biochem. 23, 87-94 (1985) https://doi.org/10.1016/0022-4731(85)90265-1